China rights to Isotechnika’s transplant drug sold to 3SBio for US million
EDMONTON – A China-based biotechnology company is making a US$ 6 million investment in Isotechnika Pharma Inc. of Edmonton (TSX:ISA). 3SBio Inc. (Nasdaq:SSRX) will receive exclusive rights for China to a drug developed by the Canadian biotech research firm to improve the success of organ transplants.
Read more on Brandon Sun
Lebanon May Roll Over .8 Billion of Eurobonds, Finance Minister Says
“We are receiving visits from investment banks who are giving us all the options,” Hassan said in an interview at her office in Beirut today. “My team is studying all the offers that we are receiving which include swapping.”
Read more on Bloomberg
Bahraini investment doubles on US trade agreement
Trade minister warns more firms need to take advantage of landmark deal.
Read more on Arabian Business
Tags: 3SBio, 3sbio Inc, Arabian Business, Beirut, Biotech Research, Biotechnology Company, Brandon Sun, China, Drug, Edmonton, Eurobonds, Finance Minister, Hassan, Investment Banks, Isa, Isotechnika, Isotechnika's, Landmark Deal, Million, Nasdaq, Organ Transplants, Pharma, Rights, Search, sold., Ssrx, Trade Minister, transplant, Tsx, US$6